EWTX R&D Expense Growth
Edgewise Therapeutics Inc · R&D Expense Growth
EWTX R&D Expense Growth
Latest reported19.24%period ending
EWTX FY R&D Growth (YoY) (0.00% → 19.24%)
Latest values, visible window
High-resolution chart · PNG
EWTX r&d expense growth history
Annual fiscal periods. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | R&D Expense Growth |
|---|---|
| 19.2359% | |
| 39.6689% | |
| 68.2429% | |
| 67.8586% | |
| 117.5226% | |
| 71.5909% | |
| 0% |